Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1070879-27-4

1070879-27-4

Post Buying Request

1070879-27-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1070879-27-4 Usage

Chemical Properties

yellow powder

Check Digit Verification of cas no

The CAS Registry Mumber 1070879-27-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,0,8,7 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1070879-27:
(9*1)+(8*0)+(7*7)+(6*0)+(5*8)+(4*7)+(3*9)+(2*2)+(1*7)=164
164 % 10 = 4
So 1070879-27-4 is a valid CAS Registry Number.

1070879-27-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail

  • Aldrich

  • (BBO000276)  4-Bromo-7-methoxyquinoline  AldrichCPR

  • 1070879-27-4

  • BBO000276-1G

  • 3,221.01CNY

  • Detail

1070879-27-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Bromo-7-methoxyquinoline

1.2 Other means of identification

Product number -
Other names 4-BROMO-7-METHOXYQUINOLINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1070879-27-4 SDS

1070879-27-4Upstream product

1070879-27-4Downstream Products

1070879-27-4Relevant articles and documents

Quinoline Derivatives and Their Use as ALK and ALK L1196M Inhibitors

-

Paragraph 0263-0264; 0310-0311, (2019/05/04)

The present invention relates to quinoline derivatives and a use thereof as inhibitors of ALK and mutated ALK. A pharmaceutical composition containing quinoline derivatives of chemical formula 1 or each of pharmaceutically acceptable salt thereof, has an effect of preventing or treating diseases associated with ALK and ALK L1196M, in other words, proliferative diseases caused by abnormal cell growth and function or behavior thereof.COPYRIGHT KIPO 2019

Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

-

Page 105, (2010/02/09)

The present invention relates to a cyclic urea compound of formula I: as defined herein. The invention is also directed to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use, as an inhibitor on a protein kinase. Thus, it is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1070879-27-4